Article Contents ::
Details About Generic Salt :: Liraglutide
Main Medicine Class:: #N/A Sub Medicine Class :: #N/A
| 8D. INSULIN & ANTI-DIABETIC DRUGS in 8. ENDOCRINE/STEROID HORMONES & METABOLIC SYSTEM |
| LIRAGLUTIDE |
| GLP-1 RECEPTOR AGONIST | ANTI-DIABETIC |
| PK: D: Vd: 13L E: Urine(6%), Feces(5%) |
|
Indications & Dose: TYPE 2 DIABETES MELLITUS SC Adult 0.6mg OD for 1wk, increase to 1.2mg OD to max 1.8mg OD |
| Contra: History of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2
Precautions: Patients with history of pancreatitis, Cholelithiasis and/or alcohol abuse, Hepatic or renal impairment, Not for use in Type 1 DM, Dose-dependant GI-related reactions ADR: Serious: Erythema, Hyperbilirubinemia, Hypertension, Hypoglycemia, influenza, nasopharyngitis, pancreatitis, papillary thyroid carcinoma, rashes, sinusitis, thyroid C-cell hyperplasia, URTI, Others: Back pain, constipation, diarrhea, dizziness, headache, nausea, vomiting DDI: Serious Thiazides Monitor: Hb A1c, Plasma glucose |
